Chloramphenicol (ophthalmic): Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 45: Line 45:
|clinicalTrials=* Blood dyscrasias may be associated with the systemic use of chloramphenicol. One case of bone-marrow hypoplasia following the prolonged (23 month) topical use of chloramphenicol ophthalmic solution has been reported.
|clinicalTrials=* Blood dyscrasias may be associated with the systemic use of chloramphenicol. One case of bone-marrow hypoplasia following the prolonged (23 month) topical use of chloramphenicol ophthalmic solution has been reported.
|postmarketing=There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label.
|postmarketing=There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label.
|useInPregnancyFDA=* '''Pregnancy Category'''
|useInPregnancyFDA=* '''Pregnancy Category'''
|useInPregnancyAUS=There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant.
|useInPregnancyAUS=There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant.
Line 59: Line 57:
|useInReproPotential=There is no FDA guidance on the use of {{PAGENAME}} in women of reproductive potentials and males.
|useInReproPotential=There is no FDA guidance on the use of {{PAGENAME}} in women of reproductive potentials and males.
|useInImmunocomp=There is no FDA guidance one the use of {{PAGENAME}} in patients who are immunocompromised.
|useInImmunocomp=There is no FDA guidance one the use of {{PAGENAME}} in patients who are immunocompromised.
|administration=* Ophthalmic
|administration=* Ophthalmic
|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.
|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.
|IVCompat=There is limited information regarding <i>IV Compatibility</i> of {{PAGENAME}} in the drug label.
|IVCompat=There is limited information regarding <i>IV Compatibility</i> of {{PAGENAME}} in the drug label.
|overdose=There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.
|overdose=There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.


Line 74: Line 65:


<!--Drug box 2-->
<!--Drug box 2-->
|structure=
|PD=There is limited information regarding <i>Pharmacodynamics</i> of {{PAGENAME}} in the drug label.
|PD=There is limited information regarding <i>Pharmacodynamics</i> of {{PAGENAME}} in the drug label.
|PK=There is limited information regarding <i>Pharmacokinetics</i> of {{PAGENAME}} in the drug label.
|PK=There is limited information regarding <i>Pharmacokinetics</i> of {{PAGENAME}} in the drug label.
|nonClinToxic=There is limited information regarding <i>Nonclinical Toxicology</i> of {{PAGENAME}} in the drug label.
|nonClinToxic=There is limited information regarding <i>Nonclinical Toxicology</i> of {{PAGENAME}} in the drug label.
|clinicalStudies=There is limited information regarding <i>Clinical Studies</i> of {{PAGENAME}} in the drug label.
|clinicalStudies=There is limited information regarding <i>Clinical Studies</i> of {{PAGENAME}} in the drug label.
|howSupplied=*
|howSupplied=*
|packLabel=<!--Patient Counseling Information-->
|packLabel=<!--Patient Counseling Information-->
Line 98: Line 78:
<!--Brand Names-->
<!--Brand Names-->
|brandNames=* ECONOCHLOR ®<ref>{{Cite web | title =chloramphenicol ointment | url =http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=29bd93cf-6524-45b9-b4b3-c9665da89e34 }}</ref>
|brandNames=* ECONOCHLOR ®<ref>{{Cite web | title =chloramphenicol ointment | url =http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=29bd93cf-6524-45b9-b4b3-c9665da89e34 }}</ref>
|lookAlike=* A® — B®<ref name="www.ismp.org">{{Cite web  | last =  | first =  | title = http://www.ismp.org | url = http://www.ismp.org | publisher =  | date =  }}</ref>
|lookAlike=* A® — B®<ref name="www.ismp.org">{{Cite web  | last =  | first =  | title = http://www.ismp.org | url = http://www.ismp.org | publisher =  | date =  }}</ref>


Revision as of 12:33, 11 May 2015

Chloramphenicol (ophthalmic)
Black Box Warning
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Black Box Warning

Warning
See full prescribing information for complete Boxed Warning.
* Bone marrow hypoplasia, including aplastic anemia and death has been reported following local application of chloramphenicol. Chloramphenicol should not be used when less potentially dangerous agents would be expected to provide effective treatment.

Overview

Chloramphenicol (ophthalmic) is a {{{drugClass}}} that is FDA approved for the treatment of {{{indication}}}. There is a Black Box Warning for this drug as shown here. Common adverse reactions include .

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Indications

  • Chloramphenicol should be used only in those serious infections for which less potentially dangerous drugs are ineffective or contraindicated. Bacteriological studies should be performed to determine the causative organisms and their sensitivity to chloramphenicol (See Box Warning). For treatment of ocular infections involving the conjunctiva and/or cornea caused by chloramphenicol-susceptible organisms.
  • Chloramphenicol has a wide spectrum of antimicrobial activity and is effective against many gram negative and gram positive bacteria, including the following common eye pathogens:
  • Staphylococcus aureus
  • Streptococci, including Streptococcus pneumoniae
  • Escherichia coli
  • Haemophilus influenzae
  • Klebsiella/Enterobacter species
  • Neisseria species
  • Moraxella lacunata (Morax-Axenfeld bacillus)
  • The product does not provide adequate coverage against:
  • Pseudomonas aeruginosa
  • Serratia marcescens

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Chloramphenicol (ophthalmic) in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Chloramphenicol (ophthalmic) in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

There is limited information regarding FDA-Labeled Use of Chloramphenicol (ophthalmic) in pediatric patients.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Chloramphenicol (ophthalmic) in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Chloramphenicol (ophthalmic) in pediatric patients.

Contraindications

  • This product is contraindicated in those persons who have shown hypersensitivity to any of its components.

Warnings

Warning
See full prescribing information for complete Boxed Warning.
* Bone marrow hypoplasia, including aplastic anemia and death has been reported following local application of chloramphenicol. Chloramphenicol should not be used when less potentially dangerous agents would be expected to provide effective treatment.
  • Ophthalmic ointment may retard corneal wound healing.

Adverse Reactions

Clinical Trials Experience

  • Blood dyscrasias may be associated with the systemic use of chloramphenicol. One case of bone-marrow hypoplasia following the prolonged (23 month) topical use of chloramphenicol ophthalmic solution has been reported.

Postmarketing Experience

There is limited information regarding Postmarketing Experience of Chloramphenicol (ophthalmic) in the drug label.

Drug Interactions

There is limited information regarding Chloramphenicol (ophthalmic) Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA):

  • Pregnancy Category


Pregnancy Category (AUS): There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Chloramphenicol (ophthalmic) in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Chloramphenicol (ophthalmic) during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Chloramphenicol (ophthalmic) with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of Chloramphenicol (ophthalmic) with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Chloramphenicol (ophthalmic) with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Chloramphenicol (ophthalmic) with respect to specific gender populations.

Race

There is no FDA guidance on the use of Chloramphenicol (ophthalmic) with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Chloramphenicol (ophthalmic) in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Chloramphenicol (ophthalmic) in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Chloramphenicol (ophthalmic) in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Chloramphenicol (ophthalmic) in patients who are immunocompromised.

Administration and Monitoring

Administration

  • Ophthalmic

Monitoring

There is limited information regarding Monitoring of Chloramphenicol (ophthalmic) in the drug label.

IV Compatibility

There is limited information regarding IV Compatibility of Chloramphenicol (ophthalmic) in the drug label.

Overdosage

There is limited information regarding Chronic Overdose of Chloramphenicol (ophthalmic) in the drug label.

Pharmacology

There is limited information regarding Chloramphenicol (ophthalmic) Pharmacology in the drug label.

Mechanism of Action

There is limited information regarding Chloramphenicol (ophthalmic) Mechanism of Action in the drug label.

Structure

There is limited information regarding Chloramphenicol (ophthalmic) Structure in the drug label.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Chloramphenicol (ophthalmic) in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Chloramphenicol (ophthalmic) in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Chloramphenicol (ophthalmic) in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Chloramphenicol (ophthalmic) in the drug label.

How Supplied

Storage

There is limited information regarding Chloramphenicol (ophthalmic) Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Chloramphenicol (ophthalmic) |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Chloramphenicol (ophthalmic) |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Patient Counseling Information of Chloramphenicol (ophthalmic) in the drug label.

Precautions with Alcohol

  • Alcohol-Chloramphenicol (ophthalmic) interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

  • ECONOCHLOR ®[1]

Look-Alike Drug Names

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

  1. ↑ "chloramphenicol ointment".
  2. ↑ "http://www.ismp.org". External link in |title= (help)

{{#subobject: 

 |Page Name=Chloramphenicol (ophthalmic)
 |Pill Name=No image.jpg
 |Drug Name=
 |Pill Ingred=|+sep=;
 |Pill Imprint=
 |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}}
 |Pill Color=|+sep=;
 |Pill Shape=
 |Pill Size (mm)=
 |Pill Scoring=
 |Pill Image=
 |Drug Author=
 |NDC=

}}

{{#subobject: 

 |Label Page=Chloramphenicol (ophthalmic)
 |Label Name=Chloramphenicol (ophthalmic)11.png

}}

{{#subobject: 

 |Label Page=Chloramphenicol (ophthalmic)
 |Label Name=Chloramphenicol (ophthalmic)11.png

}}

Retrieved from "https://www.wikidoc.org/index.php?title=Chloramphenicol_(ophthalmic)&oldid=1096113"